Austin Regional Clinic (ARC) has conducted more than 50 clinical trials since 2016 through its ARC Clinical Research program. The clinic partners with Innovo Research to explore new methods for preventing, detecting, and treating diseases that could benefit both pediatric and adult patients in the community.
Currently, ARC is enrolling participants for five different vaccine and treatment studies. These include research on pediatric migraines, chronic kidney disease, and chronic hives. Previous studies have addressed vaccines for COVID-19, chicken pox, and meningitis; diagnosis studies for autism and lung cancer; and treatment trials for arthritis, eczema, chronic kidney disease, hot flashes, and flu.
One ongoing study focuses on the multiple sclerosis medication BRIUMVI. This long-term study spans 96 weeks and monitors the drug’s effectiveness, safety profile, and patient tolerance. According to ARC, this provides Central Texas residents living with MS access to a potential new treatment while gathering data about its long-term benefits.
Another recent study at ARC investigated treatments for chronic kidney disease (CKD), particularly in patients with high proteinuria. Researchers found that a new approach reduced protein levels in urine and significantly slowed CKD progression.
“ARC has been serving the community for over 45 years. In addition to comprehensive, coordinated, primary, specialty, and surgical care, we are proud to find new ways to prevent and treat illness and disease, improve outcomes, and provide Central Texans with access to advanced medical treatment,” said Anas Daghestani, MD, President & CEO of ARC.
The clinic’s partnership with Innovo Research links it to a network of 14 medical organizations across the United States. ARC’s involvement means local patients can take part in nationwide trials that involve millions of participants and more than 150 physician-led investigation teams.
“Our partnership with Innovo Research allows ARC to expand healthcare innovation and cutting-edge research, offering patients in our community a unique value,” explains Jacques Benun, MD, FAAP, ARC Principal Investigator. “I feel fortunate to be in a position where I can make a difference in advancing medicine while helping our patients achieve their health care goals.”
Founded by three physicians in 1980, Austin Regional Clinic now serves over 700,000 area residents at 36 locations across Central Texas. The group offers primary care as well as specialty services such as Multiple Sclerosis programs and Inflammatory Bowel Disease support.
The Austin Chamber of Commerce guides regional economic efforts by supporting business events focused on innovation and education. It also promotes inclusive growth throughout neighborhoods (official website) while collaborating with local partners for community advancement initiatives.
For more information about Austin Regional Clinic or its clinical research activities visit www.austinregionalclinic.com
